drugset / Trial / NCT06085729
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
NaSingle-groupOpen-labelTreatment
Summary
To find the best dose of ADI-PEG20 that can be given in combination with carboplatin and cabazitaxel to patients with AVPC.
Timeline
- Start
- 2024-02-29
- Primary completion
- 2027-09-02
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pegargiminase | Protein / enzyme biologic | — | Other |
| Background | Cabazitaxel | Other / unclassified | — | Intravenous |
| Background | Carboplatin | Small molecule | — | Intravenous |